MAPK8 and Alzheimer disease: The study focused on investigating compound stability to modulate cognitive deficits and mitigate key signaling pathways ROS/JNK and Wnt/β-catenin implicated in AD pathology, through behavioral, biochemical, molecular, and histopathological analyses.